DTX-101(Dualitas Therapeutics Inc)

N/A

Report date: 2025/11/10 13:24:22

Base Information

Drug NameDTX-101(Dualitas Therapeutics Inc)

Drug Alias NameDTX-101DTX101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesCeliac Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDualitas Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesDualitas Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesCeliac Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A